RXI Pharmaceuticals股票价格
2020-5-11 · 金投美股网提供RXi Pharmaceuticals Corporation(RXIIW)股票行情,RXi Pharmaceuticals Corporation股票价格,RXi Pharmaceuticals Corporation股票走势分析,RXi Pharmaceuticals Corporation股票最新消息等数据分析，包括公司基本资料、重大新闻及相关 RXi Pharmaceuticals Corp. (rxii) 2017-6-22 · 交易日期 交易人 职位 类型 交易份额 价格 2017-06-22 Dispersyn (Gerrit) Officer Buy 3500 0.62 2017-06-21 Cauwenbergh (Geert) Chief Executive Officer Buy 5000 0.63 2017-06-21 Cauwenbergh (Geert) Chief Executive Officer 生物科技公司：RXi Pharmaceuticals(RXII) | 美股之 … RXi Pharmaceuticals Corporation(NASDAQ:RXII)创立于2011年9月8日，总部位于美国马萨诸塞州Marlborough，全职雇员15人，是一家生物科技公司，专注干扰自然增生的细胞机制。 最高价_安心de利帮您安心得利 最高价：是指某种币品当日交易中最高成交价格。指某种证券在每个交易日从开市到收市的交易过程中所产生的最高价格。如果当日该种证券成交价格没有发生变化,最高价就是即时价；若当日该种证券停牌,则最 …
外债债务率_安心de利帮您安心得利
RXi Pharmaceuticals Corporation (NASDAQ: RXII) stock closed at per share at the end of the most recent trading day (a % change compared to the prior day closing price) with a volume of 0.0000 shares and market capitalization of 1.45M.Is a component of indices and it is traded on NASDAQ exchange. The company belongs in the Biotechnology industry, Healthcare sector and employs people. NA (RXII) Market Cap - Zacks.com 2020-4-13 · RXi Pharmaceuticals has a market cap of $1.45 M, which represents its current share price of $0.33 multiplied by its outstanding share number of 4.38. As a small-cap company, RXII's shareholders
RXi Pharmaceuticals Corporation is a clinical-stage company developing innovative therapeutics that address significant unmet medical needs. Building on the pioneering discovery of RNAi, the Company's discovery and clinical development programs are based on its proprietary self-delivering RNAi (sd-rxRNA®) platform and Samcyprone™, a small molecule topical immunomodulator.
The requested symbol was not found in our database. Try searching for some other symbol on Yahoo Finance RXi Pharmaceuticals Real-Time Quote | Real-Time Quote RXi ...
RXI PHARMACEUTICALS CORP : News, information and stories for RXI PHARMACEUTICALS CORP | Nasdaq: | Nasdaq
RXi Pharmaceuticals Corporation(RXIIW)股票行 … 2020-5-11 · 金投美股网提供RXi Pharmaceuticals Corporation(RXIIW)股票行情,RXi Pharmaceuticals Corporation股票价格,RXi Pharmaceuticals Corporation股票走势分析,RXi Pharmaceuticals Corporation股票最新消息等数据分析，包括公司基本资料、重大新闻及相关 RXi Pharmaceuticals Corp. (rxii) 2017-6-22 · 交易日期 交易人 职位 类型 交易份额 价格 2017-06-22 Dispersyn (Gerrit) Officer Buy 3500 0.62 2017-06-21 Cauwenbergh (Geert) Chief Executive Officer Buy 5000 0.63 2017-06-21 Cauwenbergh (Geert) Chief Executive Officer 生物科技公司：RXi Pharmaceuticals(RXII) | 美股之 … RXi Pharmaceuticals Corporation(NASDAQ:RXII)创立于2011年9月8日，总部位于美国马萨诸塞州Marlborough，全职雇员15人，是一家生物科技公司，专注干扰自然增生的细胞机制。 最高价_安心de利帮您安心得利
The requested symbol was not found in our database. Try searching for some other symbol on Yahoo Finance
Phio Pharmaceuticals Phio Pharmaceuticals Reports First Quarter 2020 Financial Results and Provides Business Update; Investors. 1. Powerful Technology Platform. 6. Industry and Academic Collaborations. 9. Development Programs. 11. Million Cancer Patients to Save. Investor Relations - Phio Pharmaceuticals 2020-4-26 · Phio Pharmaceuticals is focused on developing the next generation of immuno-oncology therapeutics based on its proprietary self-delivering RNAi (INTASYL TM) therapeutic platform.Immunotherapies harness our immune system to restore surveillance of tumors that evade detection – a potential curative medicine. 外债债务率_安心de利帮您安心得利 外债债务率是指年末债务余额占当年出口收入与非贸易收入之和的比例。国际上通常认为其警戒线为100％，即年末外债余额不应大于当年出口收入和非外贸收入之和，否则可能发生偿债困难。该指标反映一国最大限度的举债能力，比重应越小越好，一般不应超过100％。 Ra Pharmaceuticals(RARX)股票股价_股价行情_财 …